Y i yang
Y i yang
The purpose of this study is to determine the efficacy and safety of levofloxacin in treating acute ischemic stroke.
Acute Ischemic Stroke
Levofloxacin
Levofloxacin simulant
NA
Acute ischemic stroke is a leading cause of disability and mortality. The investigators' previous studies suggested levofloxacin to be a newly identified neuro-protective agent, which could reduce infarct volume and improve neurologic function in animal models. To evaluate the efficacy and safety of levofloxacin in treating acute ischemic stroke patients, the prospective, multicenter and randomized controlled trial was designed.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 100 participants |
Masking : | QUADRUPLE |
Primary Purpose : | TREATMENT |
Official Title : | Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke: A Randomized Controlled Clinical Trial |
Actual Study Start Date : | 2023-06-30 |
Estimated Primary Completion Date : | 2024-06-30 |
Estimated Study Completion Date : | 2024-09-30 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years to 75 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
First Hospital of Jilin University
Changchun, Jilin, China, 130000